ATE258222T1 - Synthetische hpv11 virusartige partikel - Google Patents

Synthetische hpv11 virusartige partikel

Info

Publication number
ATE258222T1
ATE258222T1 AT96940466T AT96940466T ATE258222T1 AT E258222 T1 ATE258222 T1 AT E258222T1 AT 96940466 T AT96940466 T AT 96940466T AT 96940466 T AT96940466 T AT 96940466T AT E258222 T1 ATE258222 T1 AT E258222T1
Authority
AT
Austria
Prior art keywords
particles
hpv11
hpv6
synthetic
virus
Prior art date
Application number
AT96940466T
Other languages
English (en)
Inventor
Steven Ludmerer
Diana Benincasa
George E Mark
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9604812.9A external-priority patent/GB9604812D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE258222T1 publication Critical patent/ATE258222T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96940466T 1995-11-15 1996-11-12 Synthetische hpv11 virusartige partikel ATE258222T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US678895P 1995-11-15 1995-11-15
GBGB9604812.9A GB9604812D0 (en) 1996-03-07 1996-03-07 Synthetic HPV11 virus-like particles
PCT/US1996/018322 WO1997018301A1 (en) 1995-11-15 1996-11-12 Synthetic hpv11 virus-like particles

Publications (1)

Publication Number Publication Date
ATE258222T1 true ATE258222T1 (de) 2004-02-15

Family

ID=26308879

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96940466T ATE258222T1 (de) 1995-11-15 1996-11-12 Synthetische hpv11 virusartige partikel

Country Status (7)

Country Link
EP (1) EP0863982B1 (de)
JP (1) JP2000501285A (de)
AT (1) ATE258222T1 (de)
CA (1) CA2237224C (de)
DE (1) DE69631380T2 (de)
ES (1) ES2213185T3 (de)
WO (1) WO1997018301A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19737442C2 (de) * 1997-08-22 1999-06-24 Olfert Landt Tib Molbiol Synth Proteinumhüllte Polyribonukleinsäuren, ein Verfahren zu ihrer Herstellung und ihre Verwendung
CA2354444A1 (en) * 1998-12-17 2000-06-22 Merck & Co., Inc. Synthetic virus-like particles with heterologous epitopes
US6689366B1 (en) 1998-12-17 2004-02-10 Merck & Co., Inc. Synthetic virus like particles with heterologous epitopes
EP1501945A4 (de) * 2002-04-30 2008-02-20 Merck & Co Inc Multiplex-assay für menschliches papillomavirus
EP3191505A2 (de) * 2014-09-11 2017-07-19 Cadila Healthcare Limited Überlegene antigenen des menschlichen papillomvirus mit überlegenen immunologischen eigenschaften und impfstoff damit
US10513541B2 (en) * 2015-12-04 2019-12-24 Xiamen University Mutant of L1 protein of human papillomavirus type 11
CN114539363B (zh) * 2020-11-26 2023-12-01 中国医学科学院基础医学研究所 一种c端改造的人乳头瘤病毒11型l1蛋白及其用途
CN115028689B (zh) * 2022-06-15 2023-05-30 浙江东方基因生物制品股份有限公司 特异性检测hpv6和hpv11的双特异性检测试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1359156B1 (de) * 1991-07-19 2007-03-07 University of Queensland Impfstoff gegen Humanes Papillomavirus (Typ 18)
DE69434383T2 (de) * 1993-03-09 2005-11-24 The University Of Rochester Herstellung von menschlichem papillomavirus hüllprotein und virus-ähnlichen teilchen
DE4435907C2 (de) * 1994-10-07 1997-07-24 Lutz Prof Dr Gissmann Papillomavirusähnliche Partikel und deren Anwendung
CA2227339A1 (en) * 1995-07-19 1997-02-06 Merck & Co., Inc. Synthetic hpv11 virus-like particles

Also Published As

Publication number Publication date
EP0863982A1 (de) 1998-09-16
CA2237224C (en) 2006-06-27
EP0863982A4 (de) 2001-09-05
DE69631380T2 (de) 2004-11-04
WO1997018301A1 (en) 1997-05-22
ES2213185T3 (es) 2004-08-16
JP2000501285A (ja) 2000-02-08
EP0863982B1 (de) 2004-01-21
DE69631380D1 (de) 2004-02-26
CA2237224A1 (en) 1997-05-22

Similar Documents

Publication Publication Date Title
CA2197496A1 (fr) Composition comprenant une dispersion de particules de polymeres dans un milieu non aqueux
NZ297946A (en) Non-cell transforming variant of human papillomavirus (hpv) e6 or e7 protein which is able to elicit a humoral and/or cellular immune response
DE69824013D1 (de) Impfstoff gegen hpv
AP1872A (en) Virus-like particles of human papillomavirus.
DE69535018D1 (de) Papillomavirus vakzine
AU7351591A (en) Seroreactive epitopes of human papillomavirus (HPV) 16 proteins
WO1996030520A3 (en) Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
EP0369262A3 (de) Pyrrol-Derivate
EA200701633A1 (ru) Вакцина на основе вирусоподобных частиц вируса папилломы человека 16 и вируса папилломы человека 18 l1
WO1996029413A3 (en) Dna encoding human papilloma virus type 18
BG101105A (bg) Заместени бензамидини, тяхното получаване и използването им като лекарствени средства
DE69631380D1 (de) Synthetische hpv11 virusartige partikel
TR199802039T2 (xx) Yeni alfa-hidroksilik asit t�revleri, �retimleri ve kullan�mlar�.
ATE161177T1 (de) An sigma-bindungsstellen wirkende stoffe
TR199801039T2 (xx) Yeni fenilamidin t�revlerinin elde edilmesine y�nelik usul.
DE69635954D1 (de) Synthetische hpv-11 ähnliche partikel
TR200001182T2 (tr) Yeni karbonik asit türevleri, üretimleri ve kullanımları.
DE69726886D1 (de) Synthetische hpv16 virus-ähnliche partikel
ATE323508T1 (de) Synthetische virus-ähnliche partikel mit heterologen epitopen.
ATE260114T1 (de) Synthetische hpv-16 virusähnliche partikel
DK0750669T3 (da) Modificeret papillomavirus-L2-protein og VLP'er dannet derudfra
EP0471457A3 (de) Herpesvirus-Vektor, der ein Epitope des Maul- und Klauenseuchenviruses exprimiert
CA2256696A1 (en) Modified small rna viruses
EP0722714A3 (de) Benzoxazolderivate, ihre Verwendung als Sonnenschutzmittel und die Benzoxazolderivate enthaltende kosmetische Zusammensetzungen
ES2152343T3 (es) Polimeros de injerto con brillo superficial mejorado.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties